Measles primary prevention: Difference between revisions
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The joint press release by members of the Measles Initiative brings to light another benefit of the fight against measles: "Measles vaccination campaigns are contributing to the reduction of child deaths from other causes. They have become a channel for the delivery of other life-saving interventions, such as bed nets to protect against malaria, de-worming medicine and vitamin A supplements. Combining measles immunization with other health interventions is a contribution to the achievement of Millennium Development Goal Number 4: a two-thirds reduction in child deaths between 1990 and 2015."<ref name="UNICEF">[http://www.unicef.org/media/media_38076.html UNICEF Joint Press Release]</ref> | The joint press release by members of the Measles Initiative brings to light another benefit of the fight against [[measles]]: "Measles [[vaccination]] campaigns are contributing to the reduction of child deaths from other causes. They have become a channel for the delivery of other life-saving interventions, such as bed nets to protect against [[malaria]], de-worming medicine and [[vitamin A]] supplements. Combining measles immunization with other health interventions is a contribution to the achievement of Millennium Development Goal Number 4: a two-thirds reduction in child deaths between 1990 and 2015."<ref name="UNICEF">[http://www.unicef.org/media/media_38076.html UNICEF Joint Press Release]</ref> | ||
==Primary Prevention== | ==Primary Prevention== | ||
* The vaccination is generally not given earlier than this because children younger than 18 months usually retain anti-measles [[immunoglobulins]] (antibodies) transmitted from the mother during pregnancy. | * The [[vaccination]] is generally not given earlier than this because children younger than 18 months usually retain anti-measles [[immunoglobulins]] (antibodies) transmitted from the mother during [[pregnancy]]. | ||
* A "booster" vaccine is then given between the ages of four and five. | * A "booster" vaccine is then given between the ages of four and five. | ||
* Vaccination rates have been high enough to make measles relatively uncommon. | * Vaccination rates have been high enough to make measles relatively uncommon. | ||
Revision as of 16:14, 10 December 2012
|
Measles Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Measles primary prevention On the Web |
|
American Roentgen Ray Society Images of Measles primary prevention |
|
Risk calculators and risk factors for Measles primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
The joint press release by members of the Measles Initiative brings to light another benefit of the fight against measles: "Measles vaccination campaigns are contributing to the reduction of child deaths from other causes. They have become a channel for the delivery of other life-saving interventions, such as bed nets to protect against malaria, de-worming medicine and vitamin A supplements. Combining measles immunization with other health interventions is a contribution to the achievement of Millennium Development Goal Number 4: a two-thirds reduction in child deaths between 1990 and 2015."[1]
Primary Prevention
- The vaccination is generally not given earlier than this because children younger than 18 months usually retain anti-measles immunoglobulins (antibodies) transmitted from the mother during pregnancy.
- A "booster" vaccine is then given between the ages of four and five.
- Vaccination rates have been high enough to make measles relatively uncommon.
- Even a single case in a college dormitory or similar setting is often met with a local vaccination program, in case any of the people exposed are not already immune.